Research Interests for Henry G Grabowski

Henry G. Grabowski has been at Duke University since 1972, where he is Professor of Economics and Director of the Program in Pharmaceuticals and Health Economics. He received his undergraduate degree in Engineering Physics at Lehigh University in 1962 and Ph.D. in economics from Princeton University in 1967. He has also served on the faculty of Yale University, and held visiting appointments at the Health Care Financing Administration in Washington, D.C., and the International Institute of Management in Berlin, Germany. Professor Grabowski has published numerous studies on the economics of the pharmaceutical industry. He has investigated the costs and returns to pharmaceutical R&D, intellectual property and generic competition issues, and the effects of various government policy actions. He has been an adviser and consultant to several organizations including the National Academy of Sciences, the Institute of Medicine, the Federal Trade Commission, the General Accounting Office, and the Office of Technology Assessment.

Keywords:

Pharmaceuticals, Innovation, Regulation and Industrial Organization

Recent Publications

1. Follow-on biologics: data exclusivity and the balance between innovation and competition, Nature Reviews Drug Discovery, vol. 7 no. 6 (June, 2008), pp. 479-488
2. with Y Richard Wang, Do Faster FDA Drug Reviews Adversely Affect Patient Safety? An Analysis of the 1992 Prescription Drug User Fee Act, Journal of Law and Economics (Forthcoming 2008)
3. with Jeffrey L. Moe, Impact of Economic, Regulatory and Patent Policies on Innovation in Cancer Chemoprevention, Cancer Prevention Research (2008)
4. with JA DiMasi, Should the Patent System for New Medicines Be Abolished, Clinical Pharmacology & Therapeutics, vol. 82 no. 5 (November, 2007), pp. 488-491
5. with Jeffrey L. Moe, Impact of Economic, Regulatory and Patent Policies on Innovation in Cancer Chemoprevention, Duke Department of Economics Working Papers (November, 2007)